Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory markers in chronic hepatitis C

B F Banner1, C Allan, L Savas

  • 1Department of Pathology, University of Massachusetts Medical Center, Worcester 01655, USA.

Virchows Archiv : an International Journal of Pathology
|October 23, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

Clinical and experimental immunology·2021
Same author

Givosiran to treat acute porphyria.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Exploring the Multiple Meanings of Adaptive Management: A Case Study of the Lachlan Catchment in the Murray-Darling Basin.

Environmental management·2019
Same author

Pathology and Treatment of Coup-De-Soleil or Insolatio.

The Indian medical gazette·2017
Same author

Was It Malarious Fever or Sun-Stroke Cured by Quinine?: Naturam Morborum Remedia Ostendunt.

The Indian medical gazette·2017
Same author

Frequency and Distribution of DNA fragmentation in Hashimoto's thyroiditis and development of papillary thyroid carcinoma.

Endocrine pathology·2016

Chronic hepatitis C (HCV) inflammation involves common immune pathways, with increased T and B cells and adhesion molecules in the liver. Transforming growth factor-beta (TGF-beta) is elevated in necrotic areas, not lymphoid aggregates.

Area of Science:

  • Immunology
  • Hepatology
  • Pathology

Background:

  • Chronic inflammation in hepatitis C virus (HCV) infection is complex.
  • Understanding the immune mechanisms driving HCV inflammation is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the immune cell populations, adhesion molecules, and transforming growth factor-beta (TGF-beta) in liver biopsies from patients with chronic HCV compared to non-HCV causes of inflammation.
  • To elucidate the specific pathways involved in hepatic inflammation in chronic HCV.

Main Methods:

  • Liver biopsies from HCV (n=8) and non-HCV (n=10) patients were analyzed using immunostaining.
  • Antibodies targeted T cells (CD2, CD4, CD8), B cells (CD20), adhesion molecules (ICAM-1, VCAM-1, LFA-1), HLA-DR, and TGF-beta.

Related Experiment Videos

  • Cell counts and staining intensity were quantified and compared between groups.

    • Main Results:

    • HCV biopsies showed increased CD20+, CD4+, CD8+, and LFA-1+ cells compared to non-HCV biopsies.
    • Portal lymphoid aggregates, rich in T and B cells and expressing ICAM-1 and VCAM-1, were more frequent in HCV.
    • TGF-beta levels were elevated in areas of necrosis but not in portal lymphoid aggregates.

    Conclusions:

    • Chronic HCV inflammation is characterized by common immune-mediated cellular effector pathways.
    • Portal inflammation in HCV involves T and B cell aggregation, partly mediated by upregulated adhesion molecules.
    • TGF-beta elevation in necroinflammatory foci suggests a role in tissue damage during chronic HCV.